Audit of the autoantibody test, EarlyCDT®-Lung, in 1600 patients: An evaluation of its performance in routine clinical practice

Lung Cancer

Volumn 83, Issue 1, 2014, Pages 51-55

  Jett, James R ^a   Peek, Laura J ^b   Fredericks, Lynn ^b   Jewell, William ^b   Pingleton, William W ^b   Robertson, John F R ^b,c  

^a DEPARTMENT OF MEDICINE   (United States)

^b Oncimmune Germany GmbH   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Autoantibodies; Biomarkers; Blood test; Clinical test; Early detection; Lung cancer; Tumor associated antigens

Indexed keywords

AUTOANTIBODY;

ABNORMAL LABORATORY RESULT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CANCER STAGING; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IMMUNOASSAY; IMMUNOHISTOLOGY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MIDDLE AGED; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

AUTOANTIBODIES; BIOMARKERS; BLOOD TEST; CLINICAL TEST; EARLY DETECTION; LUNG CANCER; TUMOR-ASSOCIATED ANTIGENS;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BIOLOGICAL MARKERS; CARCINOMA, NON-SMALL-CELL LUNG; DIAGNOSTIC TESTS, ROUTINE; EARLY DETECTION OF CANCER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; QUALITY ASSURANCE, HEALTH CARE; UNITED STATES;

EID: 84891719418     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.10.008     Document Type: Article

References (17)

1. The National Lung Screening Trial Research Team Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365:395-409.
2. Swensen S.J., Jett J.R., Hartman T.E., Midthun D.E., Mandrekar S.J., Hillman S.L., et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005, 235(1):259-265.
3. Henschke C.I., McCauley D.I., Yankelevitz D.F., Naidich D.P., McGuinness G., Miettinen O.S., et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999, 354(9173):99-105.
4. Henschke C.I., Naidich D.P., Yankelevitz D.F., McGuinness G., McCauley D.I., Smith J.P., et al. Early lung cancer action project: initial findings on repeat screenings. Cancer 2001, 92(1):153-159.
5. Sobue T., Moriyama N., Kaneko M., Kusumoto M., Kobayashi T., Tsuchiya R., et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol 2002, 20(4):911-920.
6. Van Klaveren R.J., Oudkerk M., Prokop M., Scholten E.T., Nackaerts K., Vernhout R., et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009, 361:2221-2229.
7. Swensen S.J., Jett J.R., Sloan J.A., Scholten E.T., Nackaerts K., Vernhout R., et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002, 165(4):508-513.
8. Taiwo E.O., Yorio J.T., Yan J., Gerber D.E. How have we diagnosed early-stage lung cancer without radiographic screeningα A contemporary single-center experience. PLOS ONE 2012, 7(12):e52313.
9. ®-Lung test: improved clinical utility through additional autoantibody assays. Tumour Biol 2012, 33(5):1319-1326.
10. Spitz M.R., Hong W.K., Amos C.I., Wu X., Schabath M.B., Dong Q., et al. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007, 99:715-726.
11. Murray A., Chapman C.J., Healey G., Peek L.J., Parsons G., Baldwin D., et al. Technical validation of an autoantibody test for lung cancer. Ann Oncol 2010, 21(8):1687-1693.
12. Boyle P., Chapman C.J., Holdenrieder S., Murray A., Robertson C., Wood W.C., et al. Clinical validation of an autoantibody test for lung cancer. Ann Oncol 2011, 22(2):383-389.
13. Lam S., Boyle P., Healey G., Maddison P., Peek L., Murray A., et al. EarlyCDT-Lung: an immuno-biomarker test as an aid to early detection of lung cancer. Cancer Prev Res 2011, 4(7):1126-1134.
14. Chapman C.J., Thorpe A.J., Murray A., Parsy-Kowalska C.B., Allen J., Stafford K., et al. Immuno-biomarkers in small cell lung cancer: potential early clinical signals. Clin Cancer Res 2011, 17(6):1474-1480.
15. SEER cancer statistics review, 1975-2009 (vintage 2009 populations) 2012, National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, April 2012. N. Howlader, A.M. Noone, M. Krapcho, N. Neyman, R. Aminou, W. Waldron (Eds.).
16. ®-Lung serum autoantibody test on the assessment of lung cancer risk. Chest 2012, 142(4_Meeting Abstracts):638A.
17. MacMahon H., Austin J.H.M., Gamsu G., et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005, 237(2):395-400.